Private Equity Focuses on Women’s Health Trends
Kearney’s Paula Bellostas Muguerza highlighted a ‘$1 trillion gap’ attracting private equity dealmakers to the women’s health sector, according to PE Hub. Astorg, Cinven, and Nordic are targeting pathology assets amid these trends.
Deals in the Pathology Sector
The article examines deals in the pathology sector and the tailwinds supporting them, with specific mention of Astorg, Cinven, and Nordic’s interest. This follows discussions on how such sectors are drawing PE investment.
Key Transaction Highlighted
It discusses the $1.1 billion sale of EyeSouth Partners to Cencora and notes the growth of the business under Olympus Partners, illustrating PE activity in healthcare. According to PE Hub, these elements underscore ongoing sector dynamics.
Context on PE in Healthcare
As a widely-known trend, private equity has increasingly entered healthcare subsectors like women’s health and pathology due to market opportunities, though specifics here tie directly to the source material.
